INTRODUCTION
Fructose has received extensive interest as a potential risk factor for developing type 2 diabetes, but the long-term metabolic complications of fructose consumption in humans are controversial. Dietary fructose absorption is very efficient in the small intestine, mediated by the GLUT2 and GLUT5 transporters. Fructose transport by GLUT5 is a major factor for generation of fructose-induced hypertension, as demonstrated in glut5 -/-mice [1] . High levels of post-prandial fructose lead to rapid influx into the liver from the small intestine; as it bypasses hormonal signalling control, blood post-prandial fructose concentration does not rise in the same way as evidenced for glucose. This precipitates an inundation effect that can ultimately overload energy-related metabolic pathways. Fast processing of fructose by hepatic fructokinase C generates ample substrates for de novo lipogenesis leading to rising levels of uric acid and reactive oxygen species (ROS) [2] , upregulated fructokinase expression [3] and inhibition of 5' adenosine monophosphate-activated protein kinase (AMPK) activity by elevated AMP [4] . However, epidemiological studies indicate that high fructose diets per se are not associated with an increased risk of hyperuricemia [5] , implying that the stress from the rapid influx of fructose following repeated high bolus meals is a key factor in setting the liver functions at increased risk. According to numerous studies, high glycaemic index diets, even with equivalent total carbohydrate, lead to increased risk of diabetes and cardiovascular risk [6, 7] . High post-prandial glucose long-term gives rise to endothelial dysfunction, increased ROS production by complex I, and a plethora of changes in cell signalling and gene expression [8, 9] . Dietary fructose is mostly consumed with glucose, either in the form of sucrose or as high fructose corn syrups. Sucrose consists of glucose linked to fructose, and in the intestine, the brush border enzyme sucrase-isomaltase hydrolyses sucrose into its constituent sugars [10] , which are then absorbed by GLUT transporters as the free sugars. Acarbose is a drug routinely used to manage carbohydrate digestion in diabetics, and acts by inhibiting the starch digesting enzymes -amylase and enterocyte brush border -glucosidases and sucrase [11] . Up to now it has not been clear if acarbose can also directly act on intestinal sugar absorption or sugar transporters.
Foods, herbal medicines and plant extracts, often overlooked in the clinical setting, can delay the need to resort to prescribed drugs by contributing to everyday health maintenance [12, 13] or even more by eliciting complementary effects to prescribed drugs. Management and blunting of fructose absorption, without modifying the total amount of absorbed dietary fructose, could provide a route to preventing fructose-induced liver inundation postprandially and hence help to prevent some of the acute effects of fructose overload on liver metabolic processes [14] . Limiting the supply of fructose-derived lipogenic intermediates to the liver could restrict necessary substrates for excess AMP and uric acid production to below threshold and hence delay the onset of associated disease manifestations. If the same foods or beverages were able to attenuate starch digestion and glucose absorption, the potential beneficial effect would be significantly magnified. Certain polyphenols have been suggested to modify carbohydrate digestion and sugar absorption [15] . Chamomile (Matricaria recutita, also "German chamomile"), traditionally used for its "digestive" properties, has been reported to inhibit sucrase activity and decrease plasma glucose chronically in streptozotocininduced diabetic rats [16] , to interact with PPARs and improve fatty liver in high fat-fed C57BL/6 mice [17] , and to decrease glycosylated haemoglobin, serum insulin, homeostatic model assessment for insulin resistance, and serum malondialdehyde in type 2 diabetic patients [18] . Green tea (Camellia sinensis) can also improve glucose tolerance in healthy young men [19] and in rats fed a high-fat diet [20] while some of the constituent catechins can inhibit -amylase [21] . We therefore directly compared the effects of chamomile and green tea to acarbose and further examined their mechanism of action on fructose and glucose intestinal absorption, using a combination of models: the well characterised differentiated Caco-2 and Caco-2/TC7 cell monolayers, enzyme inhibition assays and oocyte-expressed sugar transporters. The Caco-2 and Caco-2/TC7 cell models have been extensively characterised, and have been utilised for studies on sugar transport as a model for the small intestine, since the expression and membrane location of GLUTs and SGLT1 is well known under a wide variety of conditions [22, 23] . In addition, the pathways for utilisation of fructose are intact since fructose can be readily used as an energy source by Caco-2 cells [24] . Here we demonstrate that chamomile and green teas have additional and complementary activities on sugar transport not exhibited by acarbose. 
MATERIALS AND METHODS

Radiolabelled
Analysis of the chamomile and green teas
Chamomile and green tea were supplied as standard dried extracts by PhytoLab & Co (Vestenbergsgreuth, Germany). Matricaria recutita ("German" chamomile) was extracted with 60% ethanol and dried, and contained added maltodextrin (50% by weight) to enhance dispersion and solubilisation. Camellia sinensis (green tea) was an aqueous extract from leaves, and dried with no additional components. Each extract was dissolved in transport buffer solution (TBS; 5.4 mM potassium chloride, 0.441 mM potassium phosphate, 0.352 mM sodium phosphate dibasic, 4.2 mM sodium bicarbonate, 1.8 mM calcium chloride dehydrate, 0.1 mM ascorbic acid and 137 mM sodium chloride, pH adjusted to 7.4 with 1M
HCl before sterile filtration) to make 10 mg/ml and centrifuged at 17,000 g for 5 min. The final extract concentration was corrected for the maltodextrin content. In preliminary experiments, we demonstrated that the relevant concentrations of maltodextrin did not interfere in any of the transport assays, but affected the digestive enzyme assays, and it was therefore removed chromatographically as described below, before testing in -amylase and -glucosidase assays.
Compositional analysis of green tea
Analysis of the green tea was performed by reversed phase high performance liquid chromatography (HPLC) on an Agilent 1200 series system (Agilent Technologies, Dorset, UK). Samples (5 µl) were injected on an Eclipse plus C18 column (30 °C, 2.1 mm x 100 mm, 1.8 m; Agilent Technologies) and separation was achieved on a gradient of 0.1% formic acid in MilliQ water (Solvent A) and 0.1% formic acid in acetonitrile (Solvent B). Elution started at 10% B at a flow rate of 0.25 ml/min and increased to 15% after 9.5 min, and after 14.5 min to 95%. Standard curves were run with commercially available standards for all compounds and used to determine concentrations, with taxifolin as the internal standard (10 µg/ml).
Compositional analysis of chamomile
Analysis of chamomile was carried out by liquid chromatography-mass spectrometry on a
Vanquish UHPLC-TSQ Quantiva triple quadrupole system (Thermo Scientific, Santa Clara, USA) with an Accucore Vanquish C18+ column (2.1 mm x 100 mm, 1.5 m; Thermo Scientific) at a flow rate of 0.3 ml/min. Solvent A was MilliQ water containing 0.1% formic acid and solvent B was acetonitrile containing 0.1% formic acid. All solvents were of mass spectrometry grade (VWR, Leicestershire, UK). Compounds were eluted with the following gradient: 0 min: 5% B, 0-5.5 min linear from to 50% B, 5.5-6 min linear from to 95% B, 6-7 min isocratic at 95% B, 7-7.1 min linear to 5% B and 7.1-9 min isocratic at 5% B.
Fragmentor voltages and collision energies were optimised for each compound using pure standards obtained from PhytoLab & Co (Vestenbergsgreuth, Germany).
Preparation of maltodextrin-free chamomile.
For enzyme inhibition studies, the maltodextrin in the chamomile preparation was removed using an ÄKTA Purifier System (GE Healthcare, Fairfield, CT, USA) controlled by a PC min isocratic at 5% B . The elution was followed at 280 nm and the polyphenol maltodextrinfree fraction was collected. Combined fractions from multiple runs were freeze-dried and stored at -20 °C.
Cell culture
The Caco-2 cell line (HTB- 
Inhibition of sugar transport using differentiated Caco-2/TC7monolayers
To further study the inhibition of GLUT2 transport by chamomile extract, the Caco-2/TC7
clone was used. Caco-2/TC7 cells were a kind gift from Prof. Monique Rousset, (INSERM, France). Cells were grown and maintained in the same medium as described above with 25 mM glucose which favours higher apical baseline levels of GLUT2 [25, 26] cells on the apical side were maintained in the same medium without FBS for the rest of the differentiation period. Glucose transport experiments were carried out as described above and 0.5 ml of TBS containing glucose and 0.15 µCi/ml with and without chamomile extract was added to the apical side and 1 ml TBS in the basal compartment. The glucose transport experiments were repeated where stated under Na + -free conditions to delineate the involvement of SGLT1.
Estimation of -amylase and -glucosidase activities
For inhibition assays, maltodextrin-free stock solutions of chamomile were reconstituted in DMSO. The maximum DMSO concentration (5%) in the assay did not affect the enzyme activity as assessed in control incubations. Inhibition of human salivary -amylase was tested as previously described [27] . Maltase, sucrase and isomaltase assays were conducted as before [28] with some modifications. An acetone extract from rat small intestine was used as the enzyme source and the assays were optimised for linearity in terms of enzyme and substrate needle syringe. The protein content was determined by the Bradford Assay in a well plate format (23200, Thermo Fisher Scientific, UK). The assay was optimised for incubation time (10 min), linearity in terms of enzyme (160 µg of total protein) and substrate concentration (10 mM sucrose), and was performed as described above. Rates were calculated relative to controls with no substrate and no enzyme.
Expression of GLUT5 in oocytes
The GLUT5 gene-containing region was extracted from SLC2A5 in pANT7_cGST plasmid coli HST08 strain) and incubated on agar plates (37 °C, 16-18 h) containing ampicillin.
Plasmids containing GLUT5 were linearized with MluI (RG381 Promega, Madison, WI, USA) and transcribed in vitro using SP6 polymerase mMESSAGE mMACHINE® (AM1340 Ambion, Applied Biosystems, Warrington, UK). Final mRNA concentration was determined with a Nanodrop ND100 spectrophotometer (Labtech, Thermo Fisher) and 1 µl of RNA product was run on 1.5%, 2.2 M formaldehyde gel to verify the size of the product. X. laevis oocytes were isolated and microinjected as previously described [29] . Ovary from adult 
Expression of GLUT2 in oocytes
Expression of GLUT2 in oocytes followed a similar protocol to that described above for Figure 1E ). The apical to basolateral transport was about 2-fold higher than in the reverse direction ( Figure 1F ).
Effect of acarbose on sugar transport across differentiated Caco-2 monolayers
Acarbose did not inhibit either glucose or fructose transport across differentiated Caco-2 cell monolayers using the optimised conditions described above. However, acarbose inhibited cellular sucrose transport efficiently in our model with an IC50 value of ~7 M (Table 1) , owing to its ability to inhibit the brush border enzyme sucrase as previously reported (see below).
Effect of chamomile and green teas on sugar transport and uptake by differentiated
Caco-2 cell monolayers
Several food and beverage extracts were screened (data not shown), and the two most active on inhibition of sugar transport, chamomile tea (German chamomile, Matricaria recutita) and green tea (Camellia sinensis) were selected. Chamomile inhibited the transport of D-[ 14 C(U)]-fructose from the apical to basolateral compartment (Figure 2A) , and the dosedependence of the effect ( Figure 2B ) allowed estimation of the IC50 value for transport, which is shown in Table 1 Figure 2D ), both in differentiated Caco-2 cell monolayers and also in Caco-2/TC7 cells (Table 1) , which express higher levels of sucrase activity [22] . During the transport experiments, tight junction integrity, assessed by TEER, was not modified by chamomile. Green tea extract also inhibited fructose, glucose and sucrose transport, the latter in both Caco-2 and Caco-2/TC7 cells (Table 1) . Green tea also increased the tight junction integrity as shown by a ~20%.increase in TEER values.
Analysis of the main components of chamomile and green tea
We analysed the extracts to determine the profile of compounds present. traces of major identified components is shown in Figure 3 and their concentration based on standard curves with commercially available standards is shown in Table 2 . Apigenin-7-O-glucoside (12.3% dry weight) was found to be the most abundant compound followed by apigenin (0.28%). The compound(s) tentatively termed as phenolic glucoside(s) have not yet been conclusively identified in the literature.
Mechanism of action of chamomile on inhibition of glucose transport
Both chamomile and green tea decreased the transport ( Figure 4A ) and uptake ( Figure 4B ) of 2-[ 14 C(U)]-deoxy-D-glucose, a non-metabolisable derivative of glucose, indicating that a major part of the effect is on glucose transport directly rather than effects on metabolism.
Caco-2 and Caco-2/TC7 cells express the sugar transporters GLUT2 (for glucose and fructose), GLUT5 (for fructose) and the sodium-dependent transporter SGLT1 (for glucose).
In order to first examine the relative inhibition of SGLT1 compared to GLUT2, experiments were conducted on glucose transport using Na + -free conditions. Both phloridzin and phloretin inhibited D-[ 14 C(U)]-glucose transport in differentiated Caco-2/TC7 cell monolayers in the presence of Na + ( Figure 5A ). Phloridzin is a well-established SGLT1 inhibitor, while phloretin inhibits GLUT2 [29] [30] [31] (Figure 5B ). In the absence of Na + , glucose transport was decreased by 35% ( Figure 5C ), implying that SGLT1 in Caco-2/TC7 cells is responsible for Figure 5D ). Under Na + -free conditions, a reduction of ~ 50 % of the IC50 value and an increase of ~ 20% of the maximum inhibition were observed ( Figure 5D ). These data suggest that SGLT1 is a minor component in inhibition of glucose transport by chamomile, with most of the inhibitory effect linked to GLUT2.
Mechanism of action of chamomile on inhibition of fructose transport
Fructose transport is sodium independent as it is through GLUT2 and GLUT5, but not through SGLT1. Inhibition of [ 14 C(U)]-fructose transport by chamomile was ~50 % lower in Caco-2/TC7 cell monolayers compared to Caco-2 cells. To dissect the mechanism further, we quantified and compared the expression of GLUT5 in the two clones. Consistently, GLUT5 mRNA expression ( Figure 6F ) was also higher (~ 2.5-fold; p≤0.01).
This characterization is consistent with the transport experiments, showing that chamomile is more effective at inhibiting fructose transport by interacting with GLUT2 compared to GLUT5.
Inhibition of GLUT5 and GLUT2 expressed in Xenopus oocytes
To establish further the mechanism of action, we expressed GLUT2 and GLUT5 in Xenopus Figure 7F ) and green tea ( Figure 7C ), but strikingly no inhibition was observed for acarbose ( Figure 7C) even at the highest concentrations tested. Data are summarized in Table 3 .
Effect of pre-incubation with chamomile on glucose, fructose and sucrose transport
To investigate if chamomile could exert an additional chronic effect on sugar transport on top of the acute effects observed, we tested a longer term incubation under several conditions ( Figure 8 ). Incubation with chamomile for 16 h did not affect the transport or uptake of glucose or fructose, but led to a small but significant decrease in sucrose transport (p≤0.05) compared to the control ( Figure 8A and B). Longer term incubation with chamomile for 96 h did not affect glucose transport ( Figure 8C ).
Inhibition of digestive enzymes
Acarbose was a potent inhibitor of brush border sucrase and of starch-digesting enzyme activities as expected; although it was found to be a much weaker inhibitor of brush border isomaltase activity. Chamomile and green tea extracts inhibited human salivary -amylase and rat maltase activities, but only green tea inhibited rat isomaltase, rat sucrase and human sucrase activities (Table 3) .
DISCUSSION
A chronic excess of dietary fructose leads to an increased risk of metabolic dysfunction. This is partly due to post-prandial pulses of fructose in the liver which cause immediate and substantial changes in ATP levels, giving rise to other metabolic changes including increased uric acid and ROS production [2, 33] . The drug acarbose is prescribed for diabetics, and is well established to act on carbohydrate digestion by inhibiting -amylase and -glucosidase activities [34] . In rats, acarbose did not modify expression of SGLT1 nor GLUT2, the major glucose transporters in the small intestine, but modulated GLUT1 expression. However, these changes did not modify overall glucose transport [35] , and furthermore, acarbose did not inhibit monosaccharide transport in rats [36] . We show here that acarbose does not directly interact with human glucose and fructose transporters, GLUT2 and GLUT5, and does not inhibit glucose or fructose transport in differentiated Caco-2 cell monolayers. Acarbose would therefore be ineffective against fructose and glucose absorption from, for example, high fructose corn syrups, which contain ~50% glucose and ~50% fructose. On the other hand, acarbose would be effective in attenuating sucrose digestion as it inhibits sucrase activity as expected [36] and indirectly slows the rate of transport of the products across the brush border through diminished substrate concentration. Chamomile and green teas, owing to their ability to inhibit both glucose and fructose transport, could be particularly beneficial for reducing liver inundation by fructose at the gastrointestinal level in addition to blunting blood glucose spikes. We propose that this can present a new and effective means to manage fructose absorption, which is increased in diabetes, partly due to increased expression of gastrointestinal GLUTs. Evidence presented here shows that the effect of chamomile is acute, since no changes in glucose or fructose transport were observed after longer term treatment with chamomile. This means that an effect on glycaemia would only be possible when the chamomile or green tea were consumed at the same time as the carbohydrate. A very small but statistically significant reduction was observed for sucrose transport following chronic incubation with chamomile. Since the enzyme sucrase catalyses the conversion of sucrose into glucose and fructose before transport, then it is possible that chamomile treatment produces a small reduction in expression of sucrase, even though chamomile was not an acute direct inhibitor of the enzyme.
The concentrations reported here as necessary for inhibition are comparable to that obtained from drinking a cup of brewed chamomile tea. If 3 g of flowers are typically added to ~100 ml boiling water, then the concentration of extracted matter in the drink would be about 3 mg/ml assuming 10% extraction. This is several-fold higher than the necessary concentration for 50% inhibition. Clearly in the case of supplements, the concentrations can be substantially higher depending on the type of supplement consumed and the dose. For green tea, the number of available products and brewing methods are vast, but if 2 g of tea is added to 100 ml water, then the concentrations required for inhibition would be readily obtained by drinking tea, and again, much higher concentrations could be achieved by taking supplements.
The proposed mechanism of inhibition is summarised in Figure 9 for chamomile and for acarbose. Acarbose strongly inhibits -amylase and -glucosidase enzymes while no effect was evident on glucose or fructose transport, presumably because the tetrasaccharide structure of acarbose is too large to fit into the active site of monosaccharide transporters.
Chamomile attenuates fructose transport across Caco-2 cells in a dose-dependent manner primarily through GLUT2 inhibition, but with some effect on GLUT5. The mild inhibition of GLUT5 accounts for the lack of total inhibition of fructose transport across the Caco-2 cells by chamomile, which does not reach 100%. The other main sugar transporter, SGLT1, does not transport fructose [37] . For glucose transport, we propose that inhibition of transport by chamomile is mostly a result of GLUT2inhibition based on data from GLUT2 expression in Xenopus oocytes, and in Caco-2/TC7 cells where the GLUT2 transport component was strongly inhibited by both phloretin (a known GLUT2-specific inhibitor [29] ) and chamomile. Paracellular transport would not be affected by any of the tested compounds or extracts, and since paracellular transport of glucose is negligible [38] , this would allow glucose transport to be effectively inhibited. Indeed, in some cases inhibition of glucose transport at high concentrations of chamomile or green tea reached ~90%. When deoxy-Dglucose was used as the test substrate, substantial inhibition was observed, since this substrate
is not metabolized further after entry into the cell, and is transported by SGLT1 and GLUT2, but not GLUT5 [39] [40] [41] . In our models we confirmed that the drug acarbose does not inhibit
any of the transport components tested, which supports the hypothesis that it could act synergistically with the chamomile or green tea on carbohydrate digestive processes in vivo (Figure 9 ), and the work presented here opens the door to further in vivo studies.
Very few compounds have been shown to directly inhibit GLUT5. Although eucalyptus leaf extract inhibited fructose absorption in rats and suppressed sucrose-induced adiposity [42] , in our hands eucalyptus extract showed no inhibition of human GLUT5 in oocytes (data not shown). GLUT5 is only weakly inhibited by chamomile and, given its involvement in fructose transport, only partial and not total inhibition of fructose absorption in the intestine can be anticipated. This implies that the effect reported here would not lead to fructose malabsorption, as fructose is not fully inhibited even with very strong chamomile tea or green tea. Instead, any attenuation in vivo would allow time for the liver to process fructose, prevent the inundation, and suppress dramatic changes in ATP levels that can activate lipogenesis and overwhelm mitochondrial circuits. Thus chamomile and green teas, which consist of a multitude of bioactive agents, could attenuate fructose absorption, which the drug acarbose cannot achieve. These results can help in the development of combined interventions enabling diabetics to manage their condition, as well as providing preventative dietary strategies to curtail hyperglycaemic stress.
sucrose). From this data, the IC50 values were calculated and shown in Table 1 . For panels B-D, letters denote differences between data points at the level of significance indicated in the panel. Where not visible, error bars are smaller than the size of the data point, which is mean ± SD (n=4-6 independent determinations). Table 1 . Effect of acarbose and herbal extracts on transport and uptake of glucose (1 mM), fructose (5 mM) and sucrose (5 mM) across differentiated Caco-2 cell monolayers. 1 In Caco-2/TC7 cells, which express higher levels of brush border sucrase. NI = no inhibition observed up to 0.5 mM. Data shown are IC50 values in mg extract/ml medium for plant extracts and in µM for acarbose. respectively; substrate for sucrase is sucrose. 4 1 For the protein extract from rat intestine, apparent Km values were 3.4, 5.7 and 18 mM for maltose, isomaltose and sucrose respectively. All 5 inhibition assays were performed in the linear part of the time and dose curves. 6 2 Human GLUT2 and GLUT5 expressed in Xenopus oocytes; sucrase as a cell-free extract from Caco-2 TC7 cells. 7 3 Maximum concentration of extract tested was 1 mg/ml 8 For sucrase inhibition: acarbose, 4 experiments in triplicate (n=12); green tea, 2 experiments in triplicate (n = 6). For GLUT2 and GLUT5 9 expressed in Xenopus oocytes, 6 replicates of 3 oocytes for each data point. For -amylase inhibition, 3 independent experiments with 3 10 technical replicates (n = 9). 11
